Cargando…

Type-specific prevalence of human papillomavirus in women screened for cervical cancer in Labrador, Canada

BACKGROUND: A higher incidence of cervical cancer and human papillomavirus (HPV) infection has been reported in northern Canada and in First Nation, Métis and Inuit women, with some evidence to suggest that the HPV type distribution in these populations may be different from the rest of Canada. OBJE...

Descripción completa

Detalles Bibliográficos
Autores principales: Severini, Alberto, Jiang, Ying, Brassard, Paul, Morrison, Howard, Demers, Alain A., Oguntuase, Elizabeth, Al-Rushdi, Muna, Preston, Felicia, Ratnam, Samuel, Mao, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Co-Action Publishing 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3579953/
https://www.ncbi.nlm.nih.gov/pubmed/23440347
http://dx.doi.org/10.3402/ijch.v72i0.19743
Descripción
Sumario:BACKGROUND: A higher incidence of cervical cancer and human papillomavirus (HPV) infection has been reported in northern Canada and in First Nation, Métis and Inuit women, with some evidence to suggest that the HPV type distribution in these populations may be different from the rest of Canada. OBJECTIVE: The objective of this study was to measure the HPV type prevalence in Labrador women to determine if significant differences in HPV types could reduce the effectiveness of HPV vaccination. DESIGN: The prevalence of HPV types was determined in 1,370 women presenting for routine pap screening in Labrador between February and November 2010. Cervical cytology and HPV genotyping were performed on the same liquid-based cytology specimens. RESULTS: The overall prevalence of HPV was 21.4%; cytological abnormalities were found in 8.8% of the participants. HPV 16 and 18 were the most common high-risk HPV types. These two types were found in 52.4% of high-grade lesions. The prevalence in HPV infections was comparable across the Labrador regions. CONCLUSIONS: The present results support the potential effectiveness of the HPV immunization program in Labrador.